Hinge Health, Inc.
NYSE:HNGEMedical - Healthcare Information Services
-$0.24 today
- Market cap
- $9.31B
- Beta
- 1.99
- P/E (TTM)
- -10.3
- EPS (TTM)
- -$6.49
Volume 1.23M
Average 1.34M
HNGE Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Hinge Health, Inc.NYSE: HNGE
Operating Margin · Q2 FY2026 · quarter ended Jun 2026
Operating margin widens to 19.0%
Operating margin was 19.0% in Q2 FY2026, up 436.5 pp from a year earlier. On a trailing-twelve-month basis it was 13.0%, up 127.5 pp year over year.
Context
- Operating margin widened in 1 of the last 2 fiscal years.
- FY2025 was the lowest level in the 3 fiscal years shown.
What to watch
Whether operating margin reaches the consensus estimate from 12 analysts of 29.6% for the fiscal year ending Dec 2026, up from -92.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 19.0%+1.4 pp QoQ
- Last fiscal yearDec 2025
- -92.9%-84.8 pp YoY
- LTMJun 2026
- 13.0%+127.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +436.5 pp | +32.0 pp | -404.5 pp |
| 1 year | -84.8 pp | +122.6 pp | +207.3 pp |
| 3 years | — | +125.2 pp | — |
| 5 years | +121.2 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -92.9%
- Year-over-year change
- -84.8pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -92.9% | -84.8pp |
| FY2024 | 2024-12-31 | -8.2% | +36.4pp |
| FY2023 | 2023-12-31 | -44.6% | — |
Operating Margin vs competitors
How HNGE compares with its peers on the latest reported figures
- HNGE's LTM Jun 2026 operating margin of 13.0% is the highest of the 5 companies compared; the peer median is 7.3%.
- Its year-over-year change of +127.5 pp is the highest of 5, against a peer median of +8.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 13.0% | +127.5 pp | — | |
| FY2025 | 12.9% | +1.6 pp | +4.3 pp | |
| LTM Mar 2026 | 12.0% | +2.3 pp | +0.0 pp | |
| LTM Apr 2026 | 2.7% | +39.1 pp | +3.7 pp | |
| LTM Mar 2026 | -2.9% | +15.0 pp | +76.5 pp | |
| Peer median (excluding HNGE) | 7.3% | +8.7 pp | +4.0 pp | |
Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 292.73M | 390.4M | 587.86M |
| Cost of Revenue | 98.55M | 89.81M | 118.56M |
| Gross Profit | 194.18M | 300.59M | 469.3M |
| Gross Margin | 66.3% | 77.0% | 79.8% |
| Research & Development | 110.06M | 100.84M | 368.14M |
| Selling, General & Admin | 214.64M | 227.54M | 639.41M |
| Operating Expenses | 324.69M | 332.5M | 1.02B |
| Depreciation & Amortization | 5.63M | 5.95M | 5.13M |
| EBITDA | (124.89M) | (18.48M) | (535.89M) |
| EBITDA Margin | -42.7% | -4.7% | -91.2% |
| Operating Income | (130.51M) | (31.91M) | (546.37M) |
| Operating Margin | -44.6% | -8.2% | -92.9% |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Other Income / Expenses | 21.97M | 20.65M | 19.11M |
| Income Before Tax | (108.55M) | (11.26M) | (527.26M) |
| Pre-Tax Margin | -37.1% | -2.9% | -89.7% |
| Income Tax Expense | (405K) | 677K | 998K |
| Net Income | (108.14M) | (11.93M) | (528.26M) |
| Net Margin | -36.9% | -3.1% | -89.9% |
| EPS (Basic) | (1.39) | (0.15) | (5.36) |
| EPS (Diluted) | (1.39) | (0.15) | (5.19) |
| Weighted Avg Shares | 78.02M | 78.02M | 79.19M |
| Weighted Avg Shares (Diluted) | 78.02M | 78.02M | 81.7M |
Hinge Health, Inc.
NYSE:HNGE
Intrinsic Alpha fair value
Locked
Current Price
$114.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.